NANI Research

Fort Wayne, Indiana 46804

1 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, End Stage Kidney Disease, End Stage Renal Disease, Kidney Transplant Rejection

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Transition of Renal Patients Using AlloSure Into Community Kidney Care — Completed
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation — Completed